550 related articles for article (PubMed ID: 11455010)
21. Altered gating of HERG potassium channels by cobalt and lanthanum.
Sanchez-Chapula JA; Sanguinetti MC
Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
[TBL] [Abstract][Full Text] [Related]
22. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders DJ; Chaudhary A
Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
[TBL] [Abstract][Full Text] [Related]
23. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
24. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
25. RNA interference reveals that endogenous Xenopus MinK-related peptides govern mammalian K+ channel function in oocyte expression studies.
Anantharam A; Lewis A; Panaghie G; Gordon E; McCrossan ZA; Lerner DJ; Abbott GW
J Biol Chem; 2003 Apr; 278(14):11739-45. PubMed ID: 12529362
[TBL] [Abstract][Full Text] [Related]
26. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
[TBL] [Abstract][Full Text] [Related]
27. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.
Fan JS; Jiang M; Dun W; McDonald TV; Tseng GN
Biophys J; 1999 Jun; 76(6):3128-40. PubMed ID: 10354437
[TBL] [Abstract][Full Text] [Related]
28. Block of HERG channels by berberine: mechanisms of voltage- and state-dependence probed with site-directed mutant channels.
Rodriguez-Menchaca A; Ferrer-Villada T; Lara J; Fernandez D; Navarro-Polanco RA; Sanchez-Chapula JA
J Cardiovasc Pharmacol; 2006 Jan; 47(1):21-9. PubMed ID: 16424781
[TBL] [Abstract][Full Text] [Related]
29. Testosterone-mediated modulation of HERG blockade by proarrhythmic agents.
Shuba YM; Degtiar VE; Osipenko VN; Naidenov VG; Woosley RL
Biochem Pharmacol; 2001 Jul; 62(1):41-9. PubMed ID: 11377395
[TBL] [Abstract][Full Text] [Related]
30. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Caballero R; Delpón E; Valenzuela C; Longobardo M; González T; Tamargo J
Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
[TBL] [Abstract][Full Text] [Related]
31. A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes.
Wang S; Liu S; Morales MJ; Strauss HC; Rasmusson RL
J Physiol; 1997 Jul; 502 ( Pt 1)(Pt 1):45-60. PubMed ID: 9234196
[TBL] [Abstract][Full Text] [Related]
32. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
Ficker E; Jarolimek W; Brown AM
Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
[TBL] [Abstract][Full Text] [Related]
33. Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes.
Malykhina AP; Shoeb F; Akbarali HI
Eur J Pharmacol; 2002 Oct; 452(3):269-77. PubMed ID: 12359267
[TBL] [Abstract][Full Text] [Related]
34. Mechanism for the effects of extracellular acidification on HERG-channel function.
Jiang M; Dun W; Tseng GN
Am J Physiol; 1999 Oct; 277(4):H1283-92. PubMed ID: 10516162
[TBL] [Abstract][Full Text] [Related]
35. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
36. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
37. Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine.
Siebrands CC; Friederich P
Anesthesiology; 2007 Mar; 106(3):523-31. PubMed ID: 17325511
[TBL] [Abstract][Full Text] [Related]
38. Local anaesthetic sensitivities of cloned HERG channels from human heart: comparison with HERG/MiRP1 and HERG/MiRP1 T8A.
Friederich P; Solth A; Schillemeit S; Isbrandt D
Br J Anaesth; 2004 Jan; 92(1):93-101. PubMed ID: 14665560
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
40. Use-dependent 'agonist' effect of azimilide on the HERG channel.
Jiang M; Dun W; Fan JS; Tseng GN
J Pharmacol Exp Ther; 1999 Dec; 291(3):1324-36. PubMed ID: 10565858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
